|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.210 EGP | 0.00% |
|
-5.47% | +6.14% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 690M 13.27M 11.51M 10.61M 9.95M 18.58M 1.27B 18.97M 127M 49.02M 612M 49.81M 48.74M 2.13B | P/E Ratio 2024 |
-33.1x | P/E Ratio 2025 | 5.7x |
|---|---|---|---|---|---|
| Enterprise Value | 847M 16.3M 14.14M 13.04M 12.21M 22.82M 1.56B 23.3M 155M 60.2M 752M 61.17M 59.85M 2.62B | EV / Sales 2024 |
3.03x | EV / Sales 2025 | 0.9x |
| Free-Float |
95.08% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -5.47% | ||
| Current month | -3.20% | ||
| 1 month | -4.72% | ||
| 3 months | -12.32% | ||
| 6 months | +6.14% | ||
| Current year | +6.14% |
| 1 week | 1.2 |  | 1.3 |
| 1 month | 1.2 | | 1.33 |
| Current year | 1.02 | | 1.68 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 01/01/2002 |
Tamir Saeed
BRD | Director/Board Member | - | 01/01/2021 |
Norbert Lurz
BRD | Director/Board Member | - | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -5.47% | -46.93% | -59.67% | 13.27M | |
| +2.16% | +3.17% | +43.57% | +160.28% | 1,035B | |
| -0.07% | +4.45% | +53.50% | +48.95% | 574B | |
| -0.08% | -0.08% | +17.37% | +62.66% | 397B | |
| +0.24% | +0.77% | +21.19% | +15.95% | 324B | |
| +0.16% | -1.68% | +23.53% | +15.18% | 281B | |
| +0.39% | +3.39% | +24.38% | +34.28% | 278B | |
| -0.15% | +3.81% | -45.62% | -48.38% | 193B | |
| +4.84% | +2.45% | +21.33% | +61.85% | 191B | |
| +3.61% | -2.56% | +15.16% | +61.12% | 156B | |
| Average | +0.94% | +0.97% | +12.75% | +35.22% | 342.99B | |
| Weighted average by Cap. | +0.59% | +2.39% | +29.33% | +72.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 520M 10M 8.68M 8M 7.5M 14M 957M 14.3M 95.42M 36.94M 462M 37.54M 36.73M 1.6B | 895M 17.2M 14.93M 13.76M 12.89M 24.09M 1.65B 24.59M 164M 63.56M 794M 64.58M 63.19M 2.76B |
| Net income | -38.1M -733K -636K -586K -549K -1.03M -70.16M -1.05M -6.99M -2.71M -33.82M -2.75M -2.69M -118M | 116M 2.23M 1.93M 1.78M 1.67M 3.12M 213M 3.18M 21.24M 8.22M 103M 8.35M 8.17M 357M |
| Net Debt | 254M 4.88M 4.24M 3.91M 3.66M 6.84M 468M 6.98M 46.61M 18.04M 225M 18.34M 17.94M 784M | 157M 3.03M 2.63M 2.42M 2.27M 4.24M 290M 4.33M 28.88M 11.18M 140M 11.36M 11.12M 486M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/06/26 | 1.210 £ | 0.00% | 25,135,000 |
| 10/06/26 | 1.210 £ | -4.72% | 36,618,700 |
| 09/06/26 | 1.270 £ | +0.79% | 16,031,054 |
| 08/06/26 | 1.260 £ | -1.56% | 53,746,932 |
| 07/06/26 | 1.280 £ | 0.00% | 31,887,071 |
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
